Testican-1-mediated epithelial–mesenchymal transition signaling confers acquired resistance to lapatinib in HER2-positive gastric cancer
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Testican-1-mediated epithelial–mesenchymal transition signaling confers acquired resistance to lapatinib in HER2-positive gastric cancer
Authors
Keywords
-
Journal
ONCOGENE
Volume 33, Issue 25, Pages 3334-3341
Publisher
Springer Nature
Online
2013-07-22
DOI
10.1038/onc.2013.285
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- SPOCK1 Is Regulated by CHD1L and Blocks Apoptosis and Promotes HCC Cell Invasiveness and Metastasis in Mice
- (2012) Yan Li et al. GASTROENTEROLOGY
- Gefitinib resistance of cancer cells correlated with TM4SF5-mediated epithelial–mesenchymal transition
- (2011) Mi-Sook Lee et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- Antitumor activity of HM781-36B, an irreversible Pan-HER inhibitor, alone or in combination with cytotoxic chemotherapeutic agents in gastric cancer
- (2011) Hyun-Jin Nam et al. CANCER LETTERS
- Dysregulation of Wnt/β-Catenin Signaling in Gastrointestinal Cancers
- (2011) Bryan D. White et al. GASTROENTEROLOGY
- Slug Confers Resistance to the Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor
- (2010) Tzu-Hua Chang et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial
- (2010) Yung-Jue Bang et al. LANCET
- Acquisition of Epithelial-Mesenchymal Transition Phenotype of Gemcitabine-Resistant Pancreatic Cancer Cells Is Linked with Activation of the Notch Signaling Pathway
- (2009) Z. Wang et al. CANCER RESEARCH
- Novel Mechanism of Lapatinib Resistance in HER2-Positive Breast Tumor Cells: Activation of AXL
- (2009) L. Liu et al. CANCER RESEARCH
- Epithelial-Mesenchymal Transitions in Development and Disease
- (2009) Jean Paul Thiery et al. CELL
- Tankyrase inhibition stabilizes axin and antagonizes Wnt signalling
- (2009) Shih-Min A. Huang et al. NATURE
- Lapatinib, a Dual EGFR and HER2 Tyrosine Kinase Inhibitor, Downregulates Thymidylate Synthase by Inhibiting the Nuclear Translocation of EGFR and HER2
- (2009) Hwang-Phill Kim et al. PLoS One
- HER2 in gastric cancer: a new prognostic factor and a novel therapeutic target
- (2008) C. Gravalos et al. ANNALS OF ONCOLOGY
- The growth inhibitory effect of lapatinib, a dual inhibitor of EGFR and HER2 tyrosine kinase, in gastric cancer cell lines
- (2008) Jin Won Kim et al. CANCER LETTERS
- Acquired Resistance to Small Molecule ErbB2 Tyrosine Kinase Inhibitors
- (2008) F. L. Chen et al. CLINICAL CANCER RESEARCH
- Assessment of a HER2 scoring system for gastric cancer: results from a validation study
- (2008) M Hofmann et al. HISTOPATHOLOGY
- Novel markers for enterochromaffin cells and gastrointestinal neuroendocrine carcinomas
- (2008) Justyna Leja et al. MODERN PATHOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search